Insider Transactions in Q1 2021 at Global Blood Therapeutics, Inc. (GBT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,297
-9.75%
|
$57,068
$44.48 P/Share
|
|
Mar 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+21.99%
|
-
|
|
Mar 01
2021
|
Eric Fink Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
859
-15.56%
|
$37,796
$44.48 P/Share
|
|
Mar 01
2021
|
Eric Fink Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+36.15%
|
-
|
|
Feb 28
2021
|
Ted W Love President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
370
+0.05%
|
$13,320
$36.21 P/Share
|
|
Feb 28
2021
|
Jung Choi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140
+0.08%
|
$5,040
$36.21 P/Share
|
|
Feb 28
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
375
+1.35%
|
$13,500
$36.21 P/Share
|
|
Feb 28
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
342
+1.72%
|
$12,312
$36.21 P/Share
|
|
Feb 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,178
-10.98%
|
$57,722
$49.49 P/Share
|
|
Feb 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,020
+21.96%
|
-
|
|
Feb 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
267
+3.35%
|
$10,947
$41.17 P/Share
|
|
Feb 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,865
-27.58%
|
$287,385
$49.49 P/Share
|
|
Feb 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,083
+36.23%
|
-
|
|
Feb 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,458
-8.34%
|
$120,442
$49.49 P/Share
|
|
Feb 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,770
+18.67%
|
-
|
|
Feb 01
2021
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,646
-2.56%
|
$227,654
$49.49 P/Share
|
|
Feb 01
2021
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,083
+6.72%
|
-
|
|
Feb 01
2021
|
Eric Fink Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
947
-28.34%
|
$46,403
$49.49 P/Share
|
|
Feb 01
2021
|
Eric Fink Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,020
+47.47%
|
-
|
|
Feb 01
2021
|
Eric Fink Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
322
+50.0%
|
$13,524
$42.6 P/Share
|
|
Feb 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,399
-15.03%
|
$166,551
$49.49 P/Share
|
|
Feb 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,395
+29.34%
|
-
|
|
Feb 01
2021
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,893
-2.26%
|
$876,757
$49.49 P/Share
|
|
Feb 01
2021
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,018
+5.04%
|
-
|